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A variety of important scientific 
issues arise from the data of Farley and 
colleagues (2006). Is CD95L an ini-
tial activator, or rather an amplifier of 
inflammation? If caspase activity is not 
required for CD95-mediated nonapop-
totic signals, are there conditions that 
allow for or block caspase activation in 
the absence of apoptosis? This regulat-
ed caspase activity may potentially be 
crucial for the proinflammatory signal 
by CD95. In contrast to the findings by 
Farley et al. (2006) with pharmacologi-
cal peptide inhibitors of caspases, the 
physiological inhibitor cFLIP appears to 
inhibit death receptor-mediated NF-κB 
activation and gene induction (Kreuz 
et al., 2004; Wachter et al., 2004). These 
variations hint at substantially different 
outcomes of CD95 receptor trigger-
ing depending on the type of inhibitor 
used. Moreover, it could be envisioned 
that physiological regulation of cFLIP 
might be highly relevant to intracellu-
lar signal deviation upon CD95 trigger-
ing. Likewise, intracellular inhibition 
of effector caspases or mitochondrial 
signaling pathways of apoptosis down-
stream of caspase-8 activation by Bcl-2 
family members or inhibitor-of-apop-
tosis proteins (IAPs) (Cory et al., 2003; 
Vaux and Silke, 2005) might inter-
fere with apoptotic, but not nonapop-
totic, signals by death receptors. This 
scenario may ultimately result in an 
uncontrolled activation of CD95-medi-
ated inflammation in the skin, but this 
hypothesis awaits further experimental 
studies. Taken together, it appears that 
CD95 is not only needed for a silent 
end of the life of keratinocytes during 
eczema but may rather contribute to 
a “going out with an (inflammatory) 
bang.” It will be interesting to deter-
mine under which conditions apoptosis 
may predominate over CD95-mediated 
inflammation in keratinocytes. This dif-
ference — subtle at first glance — of a 
death receptor-mediated signal might 
prove to be highly relevant to the quan-
titative response in the skin as the target 
organ of eczematous inflammation.
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The New Keratin Nomenclature
Rebecca M. Porter1
When the first nomenclature of the keratin protein family was published over 
20 years ago, only 19 keratins were thought to exist. Sequencing of the human 
genome has now revealed that there are 54 keratin genes. As a consequence, 
the nomenclature needed revision to apply a logical numbering system that 
includes the more recently identified keratins of the hair follicle.
Journal of Investigative Dermatology (2006) 126, 2366–2368. doi:10.1038/sj.jid.5700532
The intermediate filaments of the cyto-
skeleton in epithelial cells are made up 
of a wide variety of subtly different kera-
tin proteins. Antibodies to keratins have 
been extensively used in dermatology 
research. They are useful tools to defini-
tively identify the many different epithe-
lial cell types of the epidermis and hair 
follicle as well as to determine their dif-
ferentiation state.
The first nomenclature of keratins was 
published 24 years ago by Moll et al. 
(1982). At this time the concept of there 
being two types of keratin proteins, type I 
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keratins, with an acidic charge, and type 
II keratins, with a neutral-basic charge, 
was only just beginning to emerge. The 
requirement for equimolar amounts of 
both types to be present to form an inter-
mediate filament was not yet confirmed. 
The 18 keratins identified were thought 
to be close to the full number present. 
The numbering of the keratins was based 
on the location of each protein after two-
dimensional polyacrylamide gel electro-
phoresis according to molecular weight 
and isoelectric point. The neutral-basic 
keratins were numbered from largest to 
smallest, K1–K8, and the acidic keratins 
were numbered similarly, K9–K19. K11 
turned out to be a polymorphic variant 
of K10 that migrated faster because of a 
different number of glycine loops in the 
tail domain (Korge et al., 1992).
Although keratins of the hair shaft and 
inner root sheath had been investigated 
before 1982, it was not clear that they 
were intermediate filament proteins. 
Hard keratins of the hair shaft are more 
insoluble than the soft epithelial kera-
tins, which makes them more difficult to 
study (Lynch et al., 1986). It was therefore 
molecular biology techniques that finally 
revealed the extent of the diversity of ker-
atins required to make a hair shaft. Jürgen 
Schweizer’s group played a large part in 
identifying the eleven type I and six type 
II human hair keratin genes (Langbein et 
al., 1999; Langbein et al., 2001).
Finally, inner root sheath keratins 
were the last major group to be discov-
ered. The first of these was in mice (Sato 
et al., 1999), but it was not immunolocal-
ized until later (Steinert et al., 2003). In 
the meantime, inner root sheath keratins 
were discovered in sheep and humans 
(Bawden et al., 2001). There are now 
four type I and four type II keratins identi-
fied in the human inner root sheath. The 
localization of all the human type II inner 
root sheath keratins has been previously 
reported by Langbein and colleagues 
(Langbein et al., 2003), and, as they 
report in this issue (Langbein et al., 2006), 
they have now completed the expression 
pattern of the human type I inner root 
sheath keratins using both in situ hybrid-
ization and immunofluorescence micros-
copy with antibodies raised to peptide 
sequences unique to the four keratins.
The keratin genes are clustered at 
two loci in the genome, type I on chro-
mosome 17q21.2 and type II on chro-
mosome 12q13, with the exception of 
the type I keratin K18, which resides in 
the type II locus. In an attempt to iden-
tify all of the human keratins, both loci 
have now been completely sequenced 
(Hesse et al., 2004; Rogers et al., 2005). 
Interestingly, this revealed only four 
keratins that had not been previously 
published. One of these was a keratin 
found only in the eccrine sweat gland, 
suggesting that perhaps their identity was 
not revealed before because of limited 
expression of these keratins (Langbein 
et al., 2005). The expression of the other 
three remains to be examined in detail. 
As it is unlikely that there are other 
keratins outside the two loci, it is now 
timely to revise the nomenclature. At 
the Gordon Conference on Intermediate 
Filaments in 2004, in Oxford, a nomen-
clature committee was convened. The 
full details of the new nomenclature are 
published in the Journal of Cell Biology 
(Schweizer et al., 2006). Langbein et al. 
(2006) use this new nomenclature for the 
first time, and it is proposed that the new 
nomenclature should be adopted for all 
future keratin publications.
The new keratin nomenclature can be 
viewed as an amendment of the one cre-
ated by Moll et al. (1982), as it tries to 
keep, as far as possible, identical names 
for the keratins K1–K19, with the excep-
tion of K2e, which is now K2. The main 
changes are to the newer keratins of 
the hair shaft and inner root sheath (the 
changes are summarized in Figure 1). 
The type I inner root sheath keratins have 
undergone several name changes by dif-
ferent groups but have now been des-
ignated K25–K28. There is then a short 
gap before the hair keratins start at K31–
K40. This makes the conversion of hair 
keratins previously called Ha1–Ha8 to 
K31–K38 easier to remember. Similarly, 
the type II hair keratins previously called 
Hb1–Hb6 are now K81–K86. The type 
Figure 1. Changes to the nomenclature of the major epidermal keratins. The only change to the 
epidermal keratins is from K2e to K2. No changes in nomenclature apply to the outer root sheath or 
sebaceous gland. *The keratins of the sebaceous gland are variable in the acini and in different regions 
of the duct, and not all keratins have been indicated in the diagram. The majority of the changes apply to 
the keratins of the hair shaft and inner root sheath, which have all been renamed.
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It is proposed that 
this new keratin 
nomenclature should 
be adopted for all future 
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II inner root sheath keratins, previously 
K6irs1–K6irs4, are now named K71–K74 
and are followed by K6hf, the type II 
keratin located in the companion layer. 
K77–K80 are the type II keratins, discov-
ered by sequencing of the type II kera-
tin locus. The gene designation for each 
keratin carries the same number as the 
protein with the prefix KRT.
Although we can be almost 100% 
confident that all the human keratins 
have been identified, enough flexibility 
in the nomenclature has been provided 
to allow for the discovery of new kera-
tins in other mammals. Because keratins 
are cell type and differentiation specific, 
it is not hard to imagine that the vast dif-
ferences in morphology of the skin that 
have evolved between mammals (for 
example, elephant, dolphin, armadillo, 
duck-billed platypus, deer, porcupine) 
might coincide with a requirement for 
keratins with different structural prop-
erties. Certainly several type II keratins 
have been identified that do not exist in 
humans, including a keratin in the goril-
la and chimpanzee that is redundant in 
humans (Winter et al., 2001).
In the last 24 years, Moll et al. (1982) 
has been cited more than 4,000 times. A 
lot has happened in that time, including 
many expression studies, the identifica-
tion of almost 20 genetically inherited 
diseases caused by keratin mutations, 
the generation of more than 30 trans-
genic mice (either keratin knockouts or 
mice carrying altered keratin genes), and 
numerous in vitro structural studies and 
cellular functional studies. For Schweizer 
et al. (2006) to be cited as often in the 
next 24 years will depend on the future 
of research into keratins. Certainly the 
legacy of the last few years is the ques-
tion: why are there are so many keratins? 
This question alone should keep scien-
tists approaching keratin biology from all 
angles busy for some time to come.
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A New Nail in the CTCL Coffin
Stuart R. Lessin1
The impact of immunotherapy on the natural progression of cutaneous 
T-cell lymphoma (CTCL), particularly the mycosis fungoides and Sézary syn-
drome variants, has been based on our evolving understanding of the dis-
ease’s immunobiology.
Journal of Investigative Dermatology (2006) 126, 2368–2369. doi:10.1038/sj.jid.5700558
The characterization of the T-helper 2 
(Th2) cytokine phenotype (IL-4, IL-5, 
and IL-10 predominance) of the malig-
nant CD4+ T lymphocytes of cutaneous 
T-cell lymphoma (CTCL) has provided 
an immunologic basis for the immune 
dysfunction correlated with advancing 
stages of CTCL (Vowels et al., 1994). 
The Th2 phenotype is associated with 
IFN signal transduction pathway defects 
(Sun et al., 1998), thus rendering the 
CTCL cell devoid of endogenous IFN 
immunoregulation. These observa-
tions provided the rationale leading to 
the therapeutic use of IFNs (INF-α and 
INF-γ) in CTCL (Olsen, 2003). Further 
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